Evidence map›Paper›PMID 40550708›Full record

ArticleBMJ open2025

Community-based type 2 diabetes screening programmes designed for priority populations: a scoping review protocol.

Muhanad Ahmed Ali, Fatema Mahad Ali, David Gerstle, Aimen Zehra, Ghazal S Fazli

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muhanad Ahmed AliDepartment of Geography, Geometrics, and Environment, University of Toronto Mississauga, Mississauga, Ontario, Canada muhanadahmedali@outlook.com.ORCID http://orcid.org/0000-0002-1374-1129
Fatema Mahad AliNovo Nordisk Network for Healthy Population, University of Toronto Mississauga, Mississauga, Ontario, Canada.
David GerstleUniversity of Toronto Mississauga Library, Mississauga, Ontario, Ontario, Canada.
Aimen ZehraDepartment of Anthropology, University of Toronto Mississauga, Mississauga, Ontario, Canada.
Ghazal S FazliNovo Nordisk Network for Healthy Population, University of Toronto Mississauga, Mississauga, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes is a growing public health concern, and it continues to disproportionately impact priority populations. Although earlier and more frequent screening of diabetes promotes early detection to prevent adverse outcomes, this is a significant barrier for priority populations due to inequities that hinder access to critical preventive screening in primary care settings. The purpose of this scoping review is to better understand the design and implementation of screening and early detection of type 2 diabetes in community settings for priority populations to reduce missed or delayed diagnoses and future potential adverse outcomes.

methodsThis scoping review will adopt the methodological framework of Arksey and O'Malley and be enhanced using Levac ETHICS AND DISSEMINATION: The findings from this review will inform future diabetes screening interventions in community settings to enable an equity-informed approach in the design, planning and implementation of such strategies. Equally important, it will inform a larger project, in which the team plans to implement a community-based diabetes screening programme in Ontario, Canada.

Indexed as

Community Health ServicesDiabetes Mellitus, Type 2Mass ScreeningEarly DiagnosisHumansResearch DesignScoping Reviews as TopicDiabetes Mellitus, Type 2Health EquityPUBLIC HEALTH

Identifiers

PMID40550708
PMCPMC12186024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.